Related Experiment Video
Updated: May 4, 2026

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
Published on: June 20, 2014
Atrial cardiomyopathy in cardiac amyloidosis: clinical imaging and manifestations
Natasha Gorrie1,2,3, Paul Geenty4,5, Eleanor Rye6,7
1Victor Chang Cardiac Research Institute, Darlinghurst, NSW, Australia. n.gorrie@victorchang.edu.au.
Insights
Cardiac amyloidosis can cause atrial cardiomyopathy, impacting heart function and prognosis. This review highlights imaging and clinical outcomes related to this condition.
Area of Science:
- Cardiology
- Cardiovascular Imaging
- Amyloidosis Research
Background:
- Cardiac amyloidosis is a progressive infiltrative disease causing significant heart complications.
- Atrial abnormalities are often seen as secondary to ventricular dysfunction or arrhythmias.
- Emerging evidence suggests primary atrial defects may occur in cardiac amyloidosis.
Purpose of the Study:
- To review current evidence on atrial cardiomyopathy in cardiac amyloidosis.
- To focus on the role of imaging in diagnosing and assessing atrial cardiomyopathy.
- To correlate imaging findings with clinical outcomes in affected patients.
Main Methods:
- Literature review of studies on cardiac amyloidosis and atrial cardiomyopathy.
- Emphasis on diagnostic imaging modalities (e.g., echocardiography, cardiac MRI).
- Analysis of studies reporting clinical outcomes and prognostic markers.
Main Results:
- Atrial cardiomyopathy is increasingly recognized as a primary feature in cardiac amyloidosis.
- Imaging plays a crucial role in detecting structural and functional atrial changes.
- Atrial cardiomyopathy is associated with adverse clinical outcomes, including arrhythmias and heart failure.
Conclusions:
- Atrial cardiomyopathy is an important, often under-recognized, component of cardiac amyloidosis.
- Early identification through imaging may improve prognostic assessment.
- Further research is needed to fully elucidate the mechanisms and therapeutic implications of atrial cardiomyopathy in this disease.
Abstract:
Cardiac amyloidosis is a progressive infiltrative disease and an important cause of atrial arrhythmias, stroke and heart failure. Abnormal amyloid fibril deposition throughout the heart leads to a host of clinical manifestations and complications. Although atrial abnormalities are typically regarded as a consequence of ventricular diastolic dysfunction or atrial arrhythmias, there is emerging evidence that primary defects of atrial structure and function may be present. An atrial cardiomyopathy may be a sign of early cardiac disease, and an unrecognised independent marker of worse prognosis.This review summarizes current evidence specifically for atrial cardiomyopathy in cardiac amyloidosis, with a focus on imaging and clinical outcomes.
More Related Videos
10:04Imaging Amyloid Tissues Stained with Luminescent Conjugated Oligothiophenes by Hyperspectral Confocal Microscopy and Fluorescence Lifetime Imaging
Published on: October 20, 2017
12:15Tissue Preparation Techniques for Contrast-Enhanced Micro Computed Tomography Imaging of Large Mammalian Cardiac Models with Chronic Disease
Published on: February 8, 2022
Related Concept Videos
Mitral Stenosis II: Clinical features and Diagnostic Tests
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Myocarditis II: Clinical Features and Diagnostic Tests
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy